Portfolio company
AilsynBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company provides an artificial intelligence platform for peptide drug discovery and manufacturing services to pharmaceutical and healthcare organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NuvoBio
The company provides artificial intelligence software to design target-specific peptide therapeutics for pharmaceutical and biotechnology organisations.
Meddenovo
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
AilseBio
This biotech company develops artificial intelligence to discover therapy-induced antigens for cancer vaccines and immunotherapies for the healthcare sector.
Molecule One
This company develops an artificial intelligence platform for chemical synthesis planning and molecule discovery for pharmaceutical and biotechnology organisations.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
DaltonTx
This company provides an adaptive artificial intelligence platform for drug discovery to pharmaceutical, biotechnology and contract research organisations.
Aikium
This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.
Insilico Medicine
This company develops artificial intelligence platforms for drug discovery and design to serve pharmaceutical and biotechnology organisations.
